● Secretary
   Ms. Misia Wu
   email: misia@gate.sinica.edu.tw
   Phone: (02) 2787-1306

● NRPB Program PI and Coordinator
   Dr. Ying-Ta Wu
   email: ywu@gate.sinica.edu.tw
   Phone: (02) 2787-1237

● Compound collection and development
   Dr. Shi-Shan Mao
   email: sshanmao@gate.sinica.edu.tw
   Phone: (02) 2787-1303

● Assay Development
   Dr. T-J Rachel Cheng
   email: tingjenc@gate.sinica.edu.tw
   Phone: (02) 2787-1267

● HTS and Cheminformatics
   Dr. Ying-Ta Wu
   email: ywu@gate.sinica.edu.tw
   Phone: (02) 2787-1237

● Medicinal Chemistry
   Dr. Jim-Ming Fang
   email: jmfang@ntu.edu.tw
   Phnoe: (02) 2787-1266
              (02) 3366-1663

     
 
 

Q1:Who can have access to uHTS services?
A1: Anyone having a project approved and supported by NSC or Other agencies can apply for uHTS. This program is supported by NRPB, so we give service priority to the research projects of NRPB.

Q2 : How to arrange for a uHTS assay?
A2: As a new user, you need to complete an account application first. Please have your project information ready when working on both the Account and Project application forms. Once approved, you will be granted access to Project and Assy Managements, where you can add new project and new assay requests. You might have several assays in one project.
Note: A project is a titled research subject; an assay is one of the jobs executed in the project.

Q3: What is the status of your compound? what is the final DMSO concentration?
A3: Our compounds are solubilized in 100% DMSO and reformated to be 1 mM stock in online 1536-well plate.

 
 

 
 
最新消息
 
 
【Drug Discovery】Diabetes Drug Could Help Reduce Cardiovascular Disease
2016-09-02
世界上最常被用來治療第二型糖尿病的藥-Metformin,或許可被”藥物再利用”,用來治療非糖尿病症狀。。

http://www.dddmag.com/news/2016/08/diabetes-drug-could-help-reduce-cardiovascular-disease
--資料來源:Drug Discovery & Development
 

 

 
Copyright © 2013 中央研究院基因體研究中心. All Right Reserved
台北市南港區 115 研究院路二段 128 號 | 電話: +886-2-2787-1306 | 傳真: +886-2-2789-9931
服務時間:週一至週五 09:00-18:00 | 基因體研究中心網頁依循「中研院資訊安全規章」制訂與執行